Since its establishment in 2012, Dibier Biotech has made it its mission to lead industry progress and promote industrial upgrading. Through continuous innovation and breakthroughs, it has developed an integrated solution centered around micro-scale parallel reactors, incorporating automated instruments for medium preparation, automatic inoculation, automatic sampling, and a smart data management cloud platform. This marks a crucial step from "High Throughput Screening" to "High Throughput Process Development (HTPD)".
